Ongoing 24 Jan 2022

DECREASE

Darolutamide + Consolidation Radiotherapy in Advanced Prostate Cancer detected by PSMA.

Enquire

Trial overview

Clinical Area

Radiation Oncology

Disease / Condition

Prostate

Study Phase

Trial Identifiers

Registration number: NCT04319783

https://clinicaltrials.gov/study/NCT04319783

GenesisCare Location(s)

North Shore

Hurstville (Oncology)

Fiona Stanley Hospital (Oncology)

Principal Investigator(s)

Dr Lawrence Krieger & Dr Tee Lim & Dr Mark Sidhom

How can we help?

If you have a medical emergency please call 000. If you have an urgent request and would like to speak to our staff, please contact one of our centres directly.

* Indicates a required field.

First name *

Last name *

Email *

Phone *

State *

Postcode *

What is the reason for enquiry?

How would you prefer to be contacted? *

Phone

By submitting you acknowledge we will use the information you are providing to contact you about your enquiry. For more information about how we handle your personal information, please refer to the GenesisCare Privacy Policy.

DECREASE

Trial overview

Thank you for submitting.

An unexpected error has occurred.

How can we help?

GenesisCare

Website policies

Contact us

Media & Social